Connection
Michael Allen to Piperazines
This is a "connection" page, showing publications Michael Allen has written about Piperazines.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.234 |
|
|
|
-
Nordstrom K, Allen MH. Managing the acutely agitated and psychotic patient. CNS Spectr. 2007 Oct; 12(10 Suppl 17):5-11.
Score: 0.063
-
Daniel DG, Currier GW, Zimbroff DL, Allen MH, Oren D, Manos G, McQuade R, Pikalov AA, Crandall DT. Efficacy and safety of oral aripiprazole compared with haloperidol in patients transitioning from acute treatment with intramuscular formulations. J Psychiatr Pract. 2007 May; 13(3):170-7.
Score: 0.061
-
Stuyt EB, Sajbel TA, Allen MH. Differing effects of antipsychotic medications on substance abuse treatment patients with co-occurring psychotic and substance abuse disorders. Am J Addict. 2006 Mar-Apr; 15(2):166-73.
Score: 0.056
-
Zimbroff DL, Allen MH, Battaglia J, Citrome L, Fishkind A, Francis A, Herr DL, Hughes D, Martel M, Preval H, Ross R. Best clinical practice with ziprasidone IM: update after 2 years of experience. CNS Spectr. 2005 Sep; 10(9):1-15.
Score: 0.054